HPV Vaccine Cervarix Receives FDA Approval for Use in Cervical Cancer Prevention
Links shared publicly online about this topic
Cervarix approved for prevention of HPV-associated cervical cancer - MPR
empr.com — “The FDA has approved Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant, from GlaxoSmithKline) for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and women 10"25 years of age.” View full resource at empr.com
Most Recently Shared on October 16, 2009 at 8:55 pm By:
MPR News: Cervarix approved for prevention of HPV-associated cervical cancer: The FDA has approved Cerv.. http://bit.ly/WF8uF
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine
drugs.com — “Cervarix (Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant) is used for prevention of cervical cancer. Includes Cervarix side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 16, 2009 at 10:45 pm By:
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine - http://bit.ly/2Y6rH0
FDA Approves New Vaccine for Prevention of Cervical Cancer
fda.gov — “The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.” View full resource at fda.gov
Most Recently Shared on October 19, 2009 at 4:49 pm By:
Gannett Healthcare Health News
FDA Approves Cervarix Vaccine for Prevention of Cervical Cancer: http://bit.ly/3aQ67b
FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine | Reuters
reuters.com — “PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX [Human papillomavirus bivalent (types” View full resource at reuters.com
Most Recently Shared on October 16, 2009 at 4:16 pm By:
Skin & Allergy News Health News
RT @Apfeiffer: RT @cancercures: FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine http://bit.ly/3PBG9D
FDA approves Cervarix human papilloma vaccine as cervical cancer deterrent [Updated] | Booster Shots | Los Angeles Times
latimesblogs.latimes.com — “The food and drug administration today approved cervarix, the vaccine against human papilloma virus (hpv) manufactured by glaxosmithkline, for use in girls and young women ages 10 to 25. an fda adivsory panel recommended approval of the vaccine on sept....” View full resource at latimesblogs.latimes.com
Most Recently Shared on October 16, 2009 at 4:10 pm By:
LA Times Health News Health News
FDA approves Cervarix human papilloma vaccine as cervical cancer deterrent http://bit.ly/3NhY9x
NPR Examines Debate Over HPV Vaccination For Boys
medicalnewstoday.com — “On Friday, NPR's Morning Edition examined arguments from both sides over whether boys should receive th” View full resource at medicalnewstoday.com
Most Recently Shared on August 23, 2010 at 11:56 am By:
NPR Examines Debate Over HPV Vaccination For Boys: On Friday, NPR's "Morning Edition" examined arguments from both... http://mnt.to/f/3HJ5
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Gannett Healthcare
Nursing Spectrum, NurseWeek and www.Nurse.com
Advertisement
